医学部 小児外科学

直江 篤樹

ナオエ アツキ  (Atsuki Naoe)

基本情報

所属
藤田医科大学 医学部 医学科 小児外科学 助教
学位
学士(医学)

J-GLOBAL ID
201501008543853558
researchmap会員ID
7000012897

研究キーワード

 1

経歴

 2

学歴

 1

論文

 77
  • Shunsuke Watanabe, Mikihiro Inoue, Atsuki Naoe, Mika Murayama
    Traditional & Kampo Medicine 11(1) 3-12 2023年12月7日  
    Abstract Background Ulcerative colitis (UC) is a chronic inflammatory disease of unknown etiology. Although various new drugs have been developed in recent years, many of them are expensive, generating a demand for inexpensive and useful therapeutic drugs. Ogikenchuto (TJ‐98), an existing Kampo medicine, has been used to treat ulcers and similar conditions for some time. The current study therefore investigated whether TJ‐98 could be a new therapeutic agent for UC, a chronic inflammatory disease. Methods This study used 6‐week‐old female C57BL/6J mice to establish a mouse model of dextran sulfate sodium (DSS)‐induced colitis. We then evaluated the therapeutic effects of tacrolimus and TJ‐98 on colitis based on body weight, intestinal length, intestinal fibrosis, and cytokines. Sirius red staining was used to evaluate intestinal fibrosis, while interleukin‐1 beta (IL‐1β), interleukin‐6 (IL‐6), and tumor necrosis factor‐alpha (TNF‐α) were used to evaluate cytokines involved in inflammation. Results Neither tacrolimus nor TJ‐98 ameliorated weight loss. Although tacrolimus did not remediate intestinal shortening, intestinal fibrosis, or cytokine levels (IL‐1β, IL‐6, and TNF‐α), TJ‐98 did ameliorate intestinal shortening and intestinal fibrosis and decrease IL‐1β levels. Conclusions This study confirmed that TJ‐98 suppressed the inflammation caused by DSS‐induced enteritis and decreased the associated intestinal fibrosis, highlighting its potential as an inexpensive novel therapeutic agent for UC.
  • 近藤 靖浩, 井上 幹大, 大宮 直木, 明本 由衣, 村山 未佳, 土屋 智寛, 直江 篤樹, 渡邉 俊介, 安井 稔博, 出家 亨一, 川嶋 寛
    日本小児栄養消化器肝臓学会雑誌 37(Suppl.) 110-110 2023年10月  
  • Mika Murayama, Mikihiro Inoue, Atsuki Naoe, Toshihiro Yasui, Tatsuya Suzuki
    Clinical journal of gastroenterology 16(5) 685-688 2023年10月  
    An 11-year-old girl presented with recurrent right lower quadrant (RLQ) pain. There was no evidence of inflammation and appendiceal swelling except at the initial onset. The repeated presence of a small amount of ascites at the time of abdominal pain triggered the performance of exploratory laparoscopy. Intraoperative examination revealed a non-inflamed, unswollen appendix with a cord-like atretic segment at the middle part and an appendectomy was performed. At 46 months follow-up, she remained asymptomatic. In patients with recurrent RLQ pain of unknown cause, it is necessary to consider diagnostic laparoscopy while keeping appendiceal atresia in mind as a differential diagnosis.
  • 渡邉 俊介, 井上 幹大, 村山 未佳, 土屋 智寛, 近藤 靖浩, 直江 篤樹, 鈴木 達也
    日本小児栄養消化器肝臓学会雑誌 37(1) 25-30 2023年4月  
    排便と関連のない心窩部痛とそれに伴う腹部膨満,腹痛は機能性ディスペプシアの症状の一つであるが治療に難渋することが多い。症例は15歳女児。14歳9ヵ月時から心窩部痛,午後に腹部膨満感と腹痛があるため近医受診したが改善されず当院小児科紹介となった。血液生化学検査や腹部超音波検査は明らかな異常は認めず血液生化学検査と腹部超音波検査で有意な異常所見は認めなかったため,過敏性腸症候群の可能性を考えトリペブチンマレイン酸塩が投与された。投与開始後も症状の改善なく原因精査のため当科紹介となった。腹部単純X線検査,上部消化管造影検査から器質的疾患は認めなかった。そのため機能性ディスペプシアと診断した。15歳3ヵ月時に半夏厚朴湯を開始した。投与開始3週間後には腹部膨満感と腹痛は改善したが,心窩部痛はないも心窩部の違和感は残存していたため,半夏厚朴湯を継続し4ヵ月後に心窩部の違和感も消失し投薬中止後6ヵ月が経過したが症状の再燃は認めていない。(著者抄録)
  • Yasuhiro Kondo, Shunsuke Watanabe, Atsuki Naoe, Toshiyuki Takeuchi, Atsuko Niimi, Motoshi Suzuki, Naoya Asai, Seiji Okada, Tomonori Tsuchiya, Mika Murayama, Toshihiro Yasui, Mikihiro Inoue, Tatsuya Suzuki
    Pediatric surgery international 38(8) 1157-1163 2022年8月  
    PURPOSE: We previously reported that polyphyllin D, a main component of the traditional Chinese medicinal herb Paris polyphylla, exhibited anticancer effects in vitro against human neuroblastoma cells. The aims of this investigation was to examine the presence or absence of in vivo anti-metastasis effects of polyphyllin D were to establish a liver metastasis model of neuroblastoma and to evaluate the anti-metastasis effects of polyphyllin D. METHODS: Subcutaneous and intraperitoneal tumors, and metastasis models were established in immune-deficient BALB/c nude and BALB/c Rag-2/Jak3 double-deficient (BRJ) mice using the human neuroblastoma cell lines IMR-32, LA-N-2, or NB-69. For evaluating polyphyllin D activity, we used a mouse model of liver metastasis with the IMR-32 cells line injected through the tail vein. We analyzed the livers number and area of liver tumors in of the phosphate buffer solution- and polyphyllin D-treated groups. RESULTS: Liver metastasis and intraperitoneal dissemination models were successfully established in immune-deficient BRJ mice using the three human neuroblastoma cell lines. In the liver metastasis, the model of IMR-32 cells, we found that polyphyllin D suppressed both the number and total area of metastatic foci the average number of metastatic foci, average focus areas, and number of cleaved caspase-3-positive cells were significantly lower in the polyphyllin D group (p = 0.016, 0.020, 0.043, respectively). CONCLUSIONS: We developed a mouse models of neuroblastoma metastasis and demonstrated for the first time that polyphyllin D has an antitumor effect on neuroblastoma liver metastases.

MISC

 6
  • 宇賀 菜緒子, 土屋 智寛, 近藤 靖浩, 直江 篤樹, 渡邉 俊介, 安井 稔博, 原 普二夫, 鈴木 達也, 中谷 直史, 土田 邦博, 吉村 文, 熊本 海生航, 長尾 静子
    日本小児外科学会雑誌 55(3) 674-674 2019年5月  
  • Shunsuke Watanabe, Tatsuya Suzuki, Yasuhiro Kondo, Atsuki Naoe, Naoko Uga, Toshihiro Yasui, Fujio Hara, Tomonori Tsuchiya
    Minerva pediatrica 2019年1月2日  
    BACKGROUND: Neuroblastoma (NB) is a pediatric malignant solid tumor characterized as refractory cancer with poor prognosis. Mitosis-karyorrhexis index (MKI) is a prognostic factor but is prone to observer bias. The usefulness of MKI with Ki-67, as a marker of malignancy, was investigated. The efficacy of molecular-targeted therapeutic agents with fewer side effects in tumors has been studied. Molecular-targeted therapy targets include vascular endothelial growth factor (VEGF), involved in tumor angiogenesis; c-Kit, receptor of Kit/stem cells involved in tumor growth, vasculature, and lymphangiogenesis; platelet-derived growth factor receptor (PDGFR); and B-Raf proto-oncogene, serine/threonine kinase (BRAF), involved in the RAS protein-mediated mitogen-activated protein kinase pathway. Therefore, expression profiles of these factors and growth inhibitory effects of molecular-targeted drugs against NB were investigated. METHODS: Ten frozen NB tissue samples collected during January 1993-December 2017 were evaluated immunohistochemically for Ki-67 and VEGF. c-Kit, PDGFR, and BRAF expression levels were evaluated using enzyme-linked immunosorbent assays; relationships between these factors and clinicopathological parameters of NB were analyzed. RESULTS: Eight patients with NB showed no amplification of MYCN (MYCN proto- oncogene, bHLH transcription factor). There were two cases of ganglioneuroblastoma (GNB). More NB cells were positive for Ki-67 than for GNB cells. VEGF expression was observed in all NB specimens and was stronger in stage IIB and higher. No BRAF or c-Kit activity was observed; PDGFR activity was greater in NB than in GNB (p = 0.02). CONCLUSIONS: Thus, Ki-67 may help evaluate NB malignancy. As the first therapy for NB prevents amplification of MYCN, agents targeting PDGFR as well as VGFG can inhibit NB cell proliferation.
  • Toshihiro Yasui, Tatsuya Suzuki, Fujio Hara, Shunsuke Watanabe, Naoko Uga, Atsuki Naoe, Yasuhiro Kondo
    Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 16(6) 708-713 2018年12月  
    OBJECTIVES: In pediatric patients, renal dysfunction after living-donor liver transplant is a major issue that is difficult to evaluate. Recently, predictive equations for Japanese children have been introduced. MATERIALS AND METHODS: We conducted a retrospective study by prospectively collecting data on 26 patients under 16 years old who underwent living-donor liver transplant between June 2004 and March 2015. Serum creatinine and cystatin C levels were measured. Paired t tests and Bland-Altman plots were used to compare the following formulas for estimated glomerular filtration rate: the Schwartz formula and 3 formulas that were matched with Japanese children (polynomial, simple, and cystatin C formulas). RESULTS: Average estimated glomerular filtrations rates (in mL/min/1.73 m2) were 143.46, 122.90, 121.58, and 123.31 using the Schwartz, polynomial, simple, and cystatin C formulas, respectively. The estimated glomerular filtrations rate for biliary atresia was 141.53 ± 31.37 versus 109.95 ± 19.52 for other diseases, with significant differences only noted with the cystatin C formula. The formulas tailored for Japanese children showed significantly lower estimated glomerular filtrations rates than those obtained using the Schwartz formula (P < .01). CONCLUSIONS: The use of formulas for measuring estimated glomerular filtrations rates that are based on race may allow early detection of deteriorating renal function.
  • 大高 早希, 森 雄司, 岡本 薫, 山脇 一夫, 菅田 健, 近藤 康人, 冨重 博一, 鈴木 達也, 原 普二夫, 直江 篤樹
    日本小児科学会雑誌 122(1) 102-102 2018年1月  
  • 安井 稔博, 鈴木 達也, 原 普二夫, 渡邉 俊介, 宇賀 菜緒子, 直江 篤樹, 冨重 博一
    小児外科 47(6) 621-623 2015年6月  

講演・口頭発表等

 4

担当経験のある科目(授業)

 2